Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
212
-
Total 13F shares, excl. options
-
87.6M
-
Shares change
-
-275K
-
Total reported value, excl. options
-
$1.38B
-
Value change
-
-$4.9M
-
Put/Call ratio
-
4.7
-
Number of buys
-
104
-
Number of sells
-
-95
-
Price
-
$15.72
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2018
252 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2018.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 212 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 87.6M shares
of 106M outstanding shares and own 82.75% of the company stock.
Largest 10 shareholders include BlackRock Inc. (14.2M shares), FEDERATED INVESTORS INC /PA/ (11.9M shares), VANGUARD GROUP INC (10.3M shares), INGALLS & SNYDER LLC (7.32M shares), Consonance Capital Management LP (4.63M shares), RENAISSANCE TECHNOLOGIES LLC (4.35M shares), STATE STREET CORP (2.91M shares), ACADIAN ASSET MANAGEMENT LLC (2.79M shares), Invesco Ltd. (1.83M shares), and DIMENSIONAL FUND ADVISORS LP (1.65M shares).
This table shows the top 212 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.